Lineage LINE 深 滬
已收盤 11-06 16:00:00 美东时间
39.13
-0.400
-1.01%
華盛通- 最 高39.54
- 今 開38.83
- 成交量 124.87万股
- 最 低 38.61
- 昨 收 39.53
- 總市值 89.10亿
- 52周最高 45.2175
- 市盈率 靜 --
- 換手率 0.55%
- 52周最低 29.7325
- 委 比 -47.04%
- 總股本 2.28亿
- 歷史最高 85.235
- 量 比 1.29
- 振 幅 2.35%
- 歷史最低 29.7325
- 每 手 1
- 風險率 3.59%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Top 3 Real Estate Stocks That May Implode This Quarter
As of Nov. 6, 2026, three stocks in the real estate sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when prices g...
11-06 21:43
ProKidney Announces Eight Abstracts Selected for Presentation at the American Society of Nephrology’s Kidney Week 2026
ProKidney Corp. will present eight abstracts, including one oral presentation, at the American Society of Nephrology’s Kidney Week 2026 in Denver. The abstracts highlight rilparencel's multifactorial mechanism of action, safety profile, and kidney function stabilization in advanced CKD and type 2 diabetes. The oral presentation focuses on graft-adjacent remodeling and vascular integrity in a CKD model. Other posters cover metabolic transitioning,...
10-22 12:00
美股大行评级 | 潜在涨幅203.03%！BTIG上调Rapport Therapeutics目标价至89美元，维持"买入"评级
今日重点评级关注：BTIG：维持Rapport Therapeutics"买入"评级，目标价从75美元升至89美元；摩根士丹利：维持希捷科技"超配"评级，目标价从1187美元升至1200美元
10-21 12:30
UBS Maintains Neutral on Lineage, Lowers Price Target to $36
UBS analyst Michael Goldsmith maintains Lineage (NASDAQ:LINE) with a Neutral and lowers the price target from $45 to $36.
10-20 21:03
美股大行评级 | 潜在涨幅386.16%！摩根士丹利维持TeraWulf"超配"评级，上调目标价至65美元
今日重点评级关注：摩根士丹利：维持TeraWulf"超配"评级，目标价从62.5美元升至65美元；摩根士丹利：维持Hut 8"超配"评级，目标价从273美元升至275美元
10-13 12:30
Piper Sandler Maintains Neutral on Lineage, Lowers Price Target to $36
Piper Sandler analyst Alexander Goldfarb maintains Lineage (NASDAQ:LINE) with a Neutral and lowers the price target from $44 to $36.
10-12 23:43
美股大行评级 | 潜在涨幅405.62%！Inventiva(IVA)获Truist Securities上调目标价至18美元，维持"买入"评级
今日重点评级关注：Truist Securities：维持Inventiva"买入"评级，目标价从13美元升至18美元；富瑞：维持Sagimet Biosciences"买入"评级，目标价从25美元升至26美元
10-05 16:26
Americold Realty rises after Scotiabank upgrades to Outperform
Amercold Realty Trust (COLD) stock gained 2.5% in Friday morning trading after Scotiabank turned bullish on the stock as channel checks indicated that fundamentals are stabilizing and likely nearing a...
10-02 22:36
Scotiabank Maintains Sector Perform on Lineage, Lowers Price Target to $39
Scotiabank analyst Greg McGinniss maintains Lineage (NASDAQ:LINE) with a Sector Perform and lowers the price target from $44 to $39.
10-02 20:24
ProKidney Announces Eight Abstracts Selected for Presentation at the American Society of Nephrology’s Kidney Week 2026
ProKidney Corp. will present eight abstracts, including one oral presentation, at the American Society of Nephrology’s Kidney Week 2026. The abstracts highlight rilparencel’s multifactorial mechanism of action in chronic kidney disease (CKD), with seven non-clinical studies showing evidence of oxidative damage attenuation, metabolic dysregulation, and pro-inflammatory signaling reduction. A clinical abstract presents Phase 2 data indicating safet...
10-02 13:00
